In a study published online yesterday focused on the medical products industry—which includes medical devices, pharmaceuticals and biologics—a group of researchers found that, compared to firms with all-male boards, firms with female directors announced high-severity product recalls 28 days sooner. This is a 35% reduction in the time between when a firm was first made aware of the defect and when the firm decided to recall the defective product.
Click here for original story, A lifesaving reason to have more women on boards: ensuring consumer safety
Source: Phys.org